{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Germany Medical Instruments & Supplies news", "home_page_url": "https://sharemaestro.com/newsreel/de/healthcare/medical-instruments-supplies/", "feed_url": "https://sharemaestro.com/newsreel/de/healthcare/medical-instruments-supplies/feed.json", "description": "Latest Medical Instruments & Supplies company headlines from Germany, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:c484bca261c4a3982a6bcdde85ebbdb5a9c73ae69d053fb4c1a65ad9f7354295", "url": "https://finance.yahoo.com/healthcare/articles/u-physical-therapy-announces-cfo-113000319.html", "external_url": "https://finance.yahoo.com/healthcare/articles/u-physical-therapy-announces-cfo-113000319.html", "title": "U.S. Physical Therapy Announces CFO", "content_text": "HOUSTON, August 14, 2026--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (\"USPH\" or the \"Company\") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (\"IIP\"), today announced that Nchacha Etta will serve as the Company's Executive Vice President and Chief Financial Officer, effective as of September 1, 2026. Jason Curtis, the Company's Senior Vice President, Finance and Accounting, served as Interim CFO since April 24, 2026. Mr. Etta brings significant experience, most recently serving as Executive Vice Presi", "date_published": "2026-08-14T11:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "ESL"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "ESL", "name": "EssilorLuxottica Soci\u00e9t\u00e9 anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/75108957-e650-45aa-8204-341874bb73b6/"}]}}, {"id": "source:483dae81a8645750f94d73ba0194dddd2330f8746335755914527985d64a5d07", "url": "https://seekingalpha.com/news/4633059-sp500-nasdaq-dow-jones-outlook-stock-market?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4633059-sp500-nasdaq-dow-jones-outlook-stock-market?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "Stock index futures largely flat after S&P 500 closes at record high", "content_text": "[Wall Street New York stock exchange stock market] alexsl Stock index futures were muted on Friday after the S&P 500 closed at a record high in the previous session. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.12%, S&P 500 futures (SPX [https://seekingalpha.com/symbol/SPX]) +0.02%, and Nasdaq futures (US100:IND) -0.24%. The S&P 500 reached another intraday record on Thursday as investors weighed July producer prices, which showed wholesale inflation was unchanged from the previous month. Investors will turn to July retail sales data at 8:30 a.m. ET for fresh clues on consumer ", "date_published": "2026-08-14T08:11:29+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Macro sensitivity", "AFW"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "AFW", "name": "Align Technology, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/9ffd5a89-eca6-4387-b5de-5a4a4ccc2d17/"}]}}, {"id": "source:6d94a2828794f443fb7600fc36fdf927e9d2536c40861e5a870a9d6ffbb4958c", "url": "https://finance.yahoo.com/healthcare/articles/could-danaher-corporation-dhr-bioprocessing-001354402.html", "external_url": "https://finance.yahoo.com/healthcare/articles/could-danaher-corporation-dhr-bioprocessing-001354402.html", "title": "Could Danaher Corporation (DHR)\u2019s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?", "content_text": "When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma demand. The news hit European supplier Sartorius AG, which traded lower in response. That drop immediately spilled over to Bio-Rad Laboratories, Inc. (NYSE:BIO), holder of a $5 billion strategic stake in Sartorius, sending Bio-Rad shares down about 1% in early New York trading.", "date_published": "2026-08-14T00:13:54+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "SRT3", "SRT"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SRT3", "name": "Sartorius Aktiengesellschaft", "sentiment_url": "https://sharemaestro.com/sentiment/dcfaaded-82d3-4d3a-8310-ecd8306b2a4e/"}, {"symbol": "SRT", "name": "Sartorius Aktiengesellschaft", "sentiment_url": "https://sharemaestro.com/sentiment/a04c198e-398c-454e-a1eb-a517deaf4eef/"}]}}, {"id": "source:5971b49dee342142efd77297a630f9275b5f8928066a404b0980f77284728a39", "url": "https://finance.yahoo.com/markets/stocks/articles/stryker-13-6-3-months-174900364.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/stryker-13-6-3-months-174900364.html", "title": "Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?", "content_text": "Stryker Corporation SYK shares have risen 13.6% in the past three months, outpacing the Zacks Medical sector's 12.9% gain and the S&P 500's 1.7% advance. The move has coincided with a sharper operating recovery after a difficult first quarter. The investor question is whether improving sales, margins and production can keep supporting the stock, or whether execution demands and a richer relative valuation now make the next leg higher harder to achieve.Zacks Investment Research Image Source: Zacks Investment Research Why Stryker's Three-Month Rally Has Support Stryker's second-quarter results g", "date_published": "2026-08-13T17:49:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:352a0f3761594e28dc3c1d362f7b538ee156b891d3026295e72946763c29c5ee", "url": "https://finance.yahoo.com/markets/stocks/articles/syk-worth-buying-growth-improves-174900186.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/syk-worth-buying-growth-improves-174900186.html", "title": "Is SYK Worth Buying as Growth Improves but Execution Risks Persist?", "content_text": "Stryker Corporation SYK presents a growth-versus-execution decision. Second-quarter sales and earnings improved sharply as the company recovered from its first-quarter cybersecurity disruption, while margins expanded and demand remained broad. The case is not risk-free. Cyber remediation costs, vascular supply constraints and acquisition execution still matter. For investors, the question is whether Stryker's improving fundamentals and product pipeline justify adding exposure before those operating issues are fully resolved. SYK's Growth Case Is Stronger Than Its Risk Profile Stryker delivered", "date_published": "2026-08-13T17:49:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Deals and strategy", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:84980dbc017c4e1caacf816c96701866d11ab80a0313de34674c2e716016b3b7", "url": "https://finance.yahoo.com/markets/stocks/articles/strykers-q2-recovery-guidance-support-174900018.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/strykers-q2-recovery-guidance-support-174900018.html", "title": "Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?", "content_text": "Stryker Corporation SYK entered the second half of 2026 with momentum restored after the March cybersecurity disruption. Second-quarter sales, earnings and margins improved as production recovered, while management narrowed its full-year outlook. The next test is execution. Stryker must keep normalizing production, convert elevated backlog into shipments and support a broad product launch cycle. Those factors will determine whether the stronger second half embedded in management's expectations materializes. Stryker's Q2 Recovery Rebuilt Momentum Stryker reported second-quarter net sales of $6.", "date_published": "2026-08-13T17:49:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Guidance", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:94864b78b6281fa043ef47f6a4ab238ba5776c49580b8f36e8fbbb63ea9c121d", "url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-backs-long-133733648.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-backs-long-133733648.html", "title": "Intuitive Surgical (ISRG) Backs Long-Term Moat Amid Near-Term Volatility", "content_text": "TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve leadership transition were the significant events. All major indices ended higher, driven by resilient economic growth and strong corporate earnings. April marked a recovery from March lows, with the S&P 500 achieving record highs by early June, largely due to robust corporate earnings linked to AI capital spendi", "date_published": "2026-08-13T13:37:33+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Capital return", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:53fb05c36057c573566bfb7e8af0d607cf6f9c966d679ea9638ae9e2d7b9b533", "url": "https://finance.yahoo.com/markets/stocks/articles/nvst-buy-earnings-rebound-valuation-130400554.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/nvst-buy-earnings-rebound-valuation-130400554.html", "title": "Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?", "content_text": "Envista Holdings Corporation NVST is showing a sharper earnings recovery after a solid second quarter, with stronger profitability and raised 2026 guidance strengthening the near-term case. The offset is valuation. NVST now trades above its five-year median forward earnings multiple, leaving less room for execution setbacks even as operating momentum improves. NVST's Earnings Recovery Supports the Bull Case Adjusted earnings were 41 cents per share in the second quarter of 2026, up 57.7% year over year. Operating profit rose 73.4% to $80.3 million, while the operating margin expanded 420 basis", "date_published": "2026-08-13T13:04:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "AFW"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "AFW", "name": "Align Technology, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/9ffd5a89-eca6-4387-b5de-5a4a4ccc2d17/"}]}}, {"id": "source:53f40eb0183ab4ac381dc42e53f0c95c6e02c2bfca22e0e4a52bf13451e71d1a", "url": "https://finance.yahoo.com/markets/stocks/articles/omnicell-raises-2026-eps-outlook-125500578.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/omnicell-raises-2026-eps-outlook-125500578.html", "title": "Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins", "content_text": "Omnicell, Inc. OMCL raised its 2026 earnings outlook after a better-than-expected second quarter, but part of the profit improvement came from a one-time tariff refund. The next test is whether operating discipline can absorb higher memory-chip costs while bookings and recurring-revenue conversion remain sensitive to hospital purchasing timelines. Omnicell Lifted Its 2026 Earnings Outlook Omnicell now expects adjusted earnings of $2.15-$2.30 per share for 2026, up from $1.80-$2.00 previously. Non-GAAP EBITDA guidance increased to $175-$185 million. Second-quarter adjusted earnings reached 94 c", "date_published": "2026-08-13T12:55:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:36f6ed0610f17ab8c61df9722e382060654627cc26f4a2cbaacc208156886924", "url": "https://finance.yahoo.com/healthcare/articles/bd-bdx-q3-2026-earnings-122827670.html", "external_url": "https://finance.yahoo.com/healthcare/articles/bd-bdx-q3-2026-earnings-122827670.html", "title": "BD (BDX) Q3 2026 Earnings Call Transcript", "content_text": "Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations - Shawn Bevec Chairman, Chief Executive Officer and President - Tom Polen Executive Vice President and Chief Financial Officer - Vitor Roque Full Conference Call Transcript Operator: Hello, and welcome to BD's Third Fiscal Quarter 2026 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at (800) 688-9445 for domestic calls and area code +1 402-220-1", "date_published": "2026-08-13T12:28:27+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:21dde91cf45aaafc1aa88dd82d517e9eb638159b94236018c60cd36d06c5b677", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNYVdwaG5sOWwzd1dXN2R4RXV5S2hnQ3RhNW5UWndfMDExRnRFd0hKN2FqQWJ1TExKVnN1cXNiMkRNQ0hadzdPclBFU0hmWExlZzRSSVY3RXpvYkFUUVl4dWZxLWRBM2lYbVp3NGlVN3B2cEVOcGthTDZPUWhJT0RjamR1akMyS2N5V1BfdWt1WWRVYUl3QUVxMjA1bzZxRng1blRDVUExMHRWMUpXcmN4N2tzMFNENm5WZ1pkemN6bkFyMWhfSGNoV1R3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNYVdwaG5sOWwzd1dXN2R4RXV5S2hnQ3RhNW5UWndfMDExRnRFd0hKN2FqQWJ1TExKVnN1cXNiMkRNQ0hadzdPclBFU0hmWExlZzRSSVY3RXpvYkFUUVl4dWZxLWRBM2lYbVp3NGlVN3B2cEVOcGthTDZPUWhJT0RjamR1akMyS2N5V1BfdWt1WWRVYUl3QUVxMjA1bzZxRng1blRDVUExMHRWMUpXcmN4N2tzMFNENm5WZ1pkemN6bkFyMWhfSGNoV1R3?oc=5", "title": "Ottobock hebt Prognose f\u00fcr 2026 an \u2013 Aktie legt nach starken Quartalszahlen um 3 % zu", "content_text": "Ottobock hebt Prognose f\u00fcr 2026 an \u2013 Aktie legt nach starken Quartalszahlen um 3 % zu", "date_published": "2026-08-13T07:18:00+00:00", "authors": [{"name": "Investing.com Deutsch"}], "tags": ["Market update", "OBCK"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "OBCK", "name": "Ottobock SE & Co. KGaA        I", "sentiment_url": "https://sharemaestro.com/sentiment/1550f224-058b-4934-a584-f2273991097d/"}]}}, {"id": "source:25410716e96e51c5cd18fc9f995b2442ae533975fbbf65ffe1d43b7bdfc04808", "url": "https://finance.yahoo.com/markets/stocks/articles/jim-cramer-surprise-ai-pick-044834942.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/jim-cramer-surprise-ai-pick-044834942.html", "title": "Jim Cramer\u2019s Surprise AI Pick: Aramark (ARMK)", "content_text": "Jim Cramer has spent months tracking the expanding ripple effects of the artificial intelligence infrastructure boom. He has repeatedly pointed out how secondary beneficiaries are emerging in unexpected places. The theme took center stage when he highlighted Aramark (NYSE:ARMK) after the food services and facilities management provider delivered an exceptional quarterly report while its newly secured data center exposure served as a catalyst. During the episode of Mad Money aired on August 11, he said: I don't think people realize how important this data center theme has become. Sure, all of t", "date_published": "2026-08-13T04:48:34+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:c9437f7c9df7d454cc88beb6f60a9bfcb966bbe769c2cf6e3f76f9b179b4936b", "url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-beats-q2-211316667.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-beats-q2-211316667.html", "title": "Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In", "content_text": "Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Intuitive Surgical (ISRG) shook investors after reporting strong Q2 2026 revenue and earnings that beat expectations, while revealing slower U.S. procedure growth and rising competitive pressure from Johnson & Johnson and Chinese robotic surgery platforms. See our latest analysis for Intuitive Surgical. The Q2 surprise arrives after a tough stretch for Intuitive Surgical, with the share price down 28.6% year to date and the 1 year total shareholder return ", "date_published": "2026-08-12T21:13:16+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:c6eafdfc22d548b9106fb663c201452672aac2c3d6904920bde827aebe3c9ab0", "url": "https://finance.yahoo.com/healthcare/articles/isrgs-us-procedure-growth-slows-183300794.html", "external_url": "https://finance.yahoo.com/healthcare/articles/isrgs-us-procedure-growth-slows-183300794.html", "title": "ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?", "content_text": "Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the second quarter, down from 14% in the first quarter. da Vinci procedure growth was 17% in the fourth quarter of 2025. Management pointed to a modest adverse impact from the expiration of enhanced ACA premium subsidies. Customer feedback indicated that changes in insurance coverage and premium dynamics affected the", "date_published": "2026-08-12T18:33:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:2100e637b2916ecb584e6b354b330a6f85d10b7b8fa369baf89de13620dc54c4", "url": "https://finance.yahoo.com/markets/stocks/articles/two-years-growth-barely-change-172001135.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/two-years-growth-barely-change-172001135.html", "title": "Two Years Of Growth Barely Change What You Pay For Intuitive Surgical", "content_text": "Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high and down about 15% over the past twelve months while the S&P 500 returned 22%. A fall that size usually leaves a stock cheap. This one still costs about 37.7 times its last twelve months of adjusted earnings, and what happens to that number by 2027 turns on a price the company has not set. Where The Multiple Actually Lands In 2027 Ana", "date_published": "2026-08-12T17:20:01+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:d05af02cb38f6cffff14bb7f33d49aa5c3c8ef0bff457a7422fe9292d5d4c38c", "url": "https://finance.yahoo.com/markets/stocks/articles/national-vision-raises-outlook-higher-155813048.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/national-vision-raises-outlook-higher-155813048.html", "title": "National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter", "content_text": "By Karen Roman National Vision Holdings, Inc. (Nasdaq: EYE) said second quarter net revenue increased 2.5% to $498.8 million compared to the year prior and net income was $12.4 million against $8.7 million, with net income margin up to 2.5% from 1.8%. Diluted earnings per share were $0.15 compared to $0.11, and adjusted operating income increased 32.7% to $31.6 million, it stated. The company updated its 2026 fiscal outlook and now adjusted operating income of $119 \u2013 $139 million against a prior target of $107 \u2013 $133 million. READ MORE Once Upon a Farm Lifts 2026 Outlook Again as Q2 Revenue Su", "date_published": "2026-08-12T15:58:13+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Guidance", "ESL"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "ESL", "name": "EssilorLuxottica Soci\u00e9t\u00e9 anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/75108957-e650-45aa-8204-341874bb73b6/"}]}}, {"id": "source:afc9bcae07875098abc4a177934a99f080c6680235bfdb0a9408520e0a6ab43c", "url": "https://finance.yahoo.com/technology/ai/articles/market-chatter-meta-platforms-faces-154235800.html", "external_url": "https://finance.yahoo.com/technology/ai/articles/market-chatter-meta-platforms-faces-154235800.html", "title": "Update: Market Chatter: Meta Platforms Faces German Criminal Complaint Over AI Smart Glasses", "content_text": "(Updates with response from a Meta Platforms spokesperson in the fourth paragraph.) Meta Platform PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in", "date_published": "2026-08-12T15:42:35+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "ESL", "FIE"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "ESL", "name": "EssilorLuxottica Soci\u00e9t\u00e9 anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/75108957-e650-45aa-8204-341874bb73b6/"}, {"symbol": "FIE", "name": "Fielmann Group AG", "sentiment_url": "https://sharemaestro.com/sentiment/a22d0392-df1e-4b41-868c-e189e3f80355/"}]}}, {"id": "source:1a2f40c9baba16791fafa02e496aab8f277ad40842ea3d434963cc20daa39c8d", "url": "https://finance.yahoo.com/healthcare/articles/intuitive-surgical-apos-competitors-face-153642167.html", "external_url": "https://finance.yahoo.com/healthcare/articles/intuitive-surgical-apos-competitors-face-153642167.html", "title": "Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says", "content_text": "Intuitive Surgical's (ISRG) competitors face unique workflow challenges and real estate issues that impact their long-term appeal, while customized price-volume contracts complicate competitors' return on investment and its flexible per-click model allows growth opportunities in Silver Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade now", "date_published": "2026-08-12T15:36:42+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:b6c247a0d79e061900beb9e83dd296a0ce0ae42e1374c0bfd3a92cced7565adf", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNd016dzVIb2o3RWVDWWt1M3dmR3cxWGZMYlo1N0NiT1ktUm9kLWFJa19BemlVa1hwTWxHUkF2UmhxdFMxbVZoS1c4aGlybmtlVzZLaUJ2alctd1hkLXUtTzRYSUIwMS1FamZERFdqeEZwOW80TkZGMWJTaTEtQktUR19XSlF3ekdWYk1wNHN0QjMyQXRIdGUzcWdBa295UkdNbDJhR2pqMjlJQ3lzWEhUUW92ZS1SM2hzRVR5VjVUb3FuWWpINy1wUHhB?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNd016dzVIb2o3RWVDWWt1M3dmR3cxWGZMYlo1N0NiT1ktUm9kLWFJa19BemlVa1hwTWxHUkF2UmhxdFMxbVZoS1c4aGlybmtlVzZLaUJ2alctd1hkLXUtTzRYSUIwMS1FamZERFdqeEZwOW80TkZGMWJTaTEtQktUR19XSlF3ekdWYk1wNHN0QjMyQXRIdGUzcWdBa295UkdNbDJhR2pqMjlJQ3lzWEhUUW92ZS1SM2hzRVR5VjVUb3FuWWpINy1wUHhB?oc=5", "title": "Die Becton-Dickinson-Aktie legt nach starken Q3-Zahlen und h\u00f6herer Prognose zu", "content_text": "Die Becton-Dickinson-Aktie legt nach starken Q3-Zahlen und h\u00f6herer Prognose zu", "date_published": "2026-08-12T14:47:14+00:00", "authors": [{"name": "AD HOC NEWS"}], "tags": ["Market update", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:b0259a224d0109f83881d0016c1981c58205f0f8dc852f77da3bc09682efd352", "url": "https://www.nasdaq.com/articles/intuitive-surgical-isrg-stock-has-plunged-33-2026-heres-why-one-fund-manager-remains", "external_url": "https://www.nasdaq.com/articles/intuitive-surgical-isrg-stock-has-plunged-33-2026-heres-why-one-fund-manager-remains", "title": "Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.", "content_text": "Key Points The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it. The Baron Health Care Fund sees Intuitive Surgical as full of promise.10 stocks we like better than Intuitive Surgical \u203a If you're not familiar with Intuitive Surgical(NASDAQ: ISRG), know this: It's a massive robotic surgical systems specialist, with a recent market value topping $135 billion. That market value was quite a bit higher not so long ago, though -- because while the stock has averaged annual gains of 17% over the past decad", "date_published": "2026-08-12T13:20:00+00:00", "authors": [{"name": "nasdaq.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:51d09f49a249edf74240a838044ca42e1d3db275594bc2a3bd21270e54e907de", "url": "https://finance.yahoo.com/healthcare/articles/intuitive-surgical-oppenheimer-now-bullish-125931309.html", "external_url": "https://finance.yahoo.com/healthcare/articles/intuitive-surgical-oppenheimer-now-bullish-125931309.html", "title": "Intuitive Surgical: Oppenheimer now bullish, sees competition being \"crowded out\"", "content_text": "Investing.com -- Oppenheimer upgraded Intuitive Surgical to Outperform from Perform with a $500 price target in a note on Wednesday, arguing the company's strategy of \"Crowding Out Competitors\" is strategically smart. Analyst Suraj Kalia said the change reflects \"a more nuanced risk-reward assessment at these levels.\" On the positive side, the firm views U.S. competition as a \"non-factor,\" with field checks suggesting \"some unique workflow challenges for Ottava that limit long-term appeal\" and real-estate issues for Hugo. It added that Intuitive's customized price-volume contracts complicate c", "date_published": "2026-08-12T12:59:31+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:0f730957215724fed72c0676028ca481b671a1c667c1d0f654137bf7849ad1c6", "url": "https://finance.yahoo.com/markets/stocks/articles/invested-1000-intuitive-surgical-inc-123002658.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/invested-1000-intuitive-surgical-inc-123002658.html", "title": "If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now", "content_text": "For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in investing, especially with particular tech giants, as well as popular consumer-facing stocks. What if you'd invested in Intuitive Surgical, Inc. (ISRG) ten years ago? It may not have been easy to hold on to ISRG for all that time, but if you did, how much would your investment be worth today? Intuitive Surgical, Inc.'s Business In-Depth ", "date_published": "2026-08-12T12:30:02+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:93a8437a003e42bdc1cec61e325e382b08164d5e79e56bcc2ecbd8cc4c72cb21", "url": "https://finance.yahoo.com/markets/stocks/articles/oppenheimer-sees-500-intuitive-surgical-122519688.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/oppenheimer-sees-500-intuitive-surgical-122519688.html", "title": "Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall", "content_text": "This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson & Johnson's (NYSE:JNJ) Ottava system and physical footprint constraints for Medtronic's (NYSE:MDT) Hugo, potentially leaving the da Vinci franchise without a credible domestic challenger in the near term. Oppenheimer also pointed to the Per Click Model as a way into lower-acuity ambulator", "date_published": "2026-08-12T12:25:19+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:265e31f0158beda66b31764a5804ec15e24d1e6a508d696cb991ee80739ce24e", "url": "https://finance.yahoo.com/markets/stocks/articles/wednesday-top-wall-street-analyst-115341914.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/wednesday-top-wall-street-analyst-115341914.html", "title": "Here Are Wednesday\u2019s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Mariott International, Merck, Novo Nordisk, Okta, and More", "content_text": "Pre-Market Stock Futures: Futures are trading modestly higher as we have arrived at the day everyone on Wall Street has circled on their calendars. The July consumer price index will be released at 8:30 AM EDT, and the producer price index will be released at the same time tomorrow. Economists forecast headline CPI to rise 0.1% month-over-month and 3.4% year-over-year, with core CPI expected to increase 0.2% month-over-month and 2.5% year-over-year. One thing is for sure; if the numbers come in hot and above expectations, the stock market could see a bout of heavy selling. All of the major ind", "date_published": "2026-08-12T11:53:41+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:6ff49d0a829f91fce502af79593937b3b79e0a85a20d267fc8f4668d4ba6243f", "url": "https://finance.yahoo.com/healthcare/articles/bd-accelerates-advanced-tissue-regeneration-105000449.html", "external_url": "https://finance.yahoo.com/healthcare/articles/bd-accelerates-advanced-tissue-regeneration-105000449.html", "title": "BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial", "content_text": "Enrollment completed in the first large-scale randomized study evaluating Phasix\u2122 Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery FRANKLIN LAKES, N.J., Aug. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a significant milestone in its advanced tissue regeneration strategy and expansion efforts with successful completion of enrollment in the PREVENT clinical trial evaluating Phasix\u2122 Mesh for the prevention of incisional hernias.Phasix Flat Mesh The study enrolled 47", "date_published": "2026-08-12T10:50:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Regulatory and legal", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:75888f862fb99d1fc168057a6c9e61e2eacc5651a5ffc663765ed1e846246f77", "url": "https://finance.yahoo.com/healthcare/articles/align-technology-prevails-china-patent-081959814.html", "external_url": "https://finance.yahoo.com/healthcare/articles/align-technology-prevails-china-patent-081959814.html", "title": "Align Technology Prevails in China Patent Infringement Action", "content_text": "Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China issued a judgment in its favor, in a patent infringement action against Angelalign Technology's operating subsidiaries in China.The company provides an orthodontic treatment system Silver Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade now", "date_published": "2026-08-12T08:19:59+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Regulatory and legal", "AFW"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AFW", "name": "Align Technology, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/9ffd5a89-eca6-4387-b5de-5a4a4ccc2d17/"}]}}, {"id": "source:62c2b790a504d8ab741a3bfe66a712bd019051a2be167b5862c1efdcc1ff53a7", "url": "https://finance.yahoo.com/healthcare/articles/align-technology-prevails-china-patent-004700024.html", "external_url": "https://finance.yahoo.com/healthcare/articles/align-technology-prevails-china-patent-004700024.html", "title": "Align Technology Prevails in China Patent Infringement Action Against Angelalign", "content_text": "SAN JOSE, Calif. & TEMPE, Ariz., August 12, 2026--(BUSINESS WIRE)--Align Technology, Inc. (\"Align\") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China (\"Angel\") (Hong Kong Stock Exchange: 6699.HK). In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People's Court, asserting Align's patent related to extraction-gap-closure technology (CN113693748B). On August 10, 2026, the Jinan Intermediate People's Court issued a first-instance judgment finding that Angel's use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align's patent. Angel may appeal the judgment to the Supreme People's Court. The deadline for filing an appeal has not yet expired. The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10 million in damages. While the ruling remains subject to appeal, Align believes the decision further reinforces the strength of its intellectual property portfolio and ongoing commitment to protecting its innovations globally. The ruling follows other recent developments in Align's patent-enforcement actions against Angel. In February 2026, the Unified Patent Court (\"UPC\") issued a preliminary injunction requiring Angel to cease infringement of Align's patented ClinCheck\u00ae Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission (\"ITC\") conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align's claims in November 2026. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe. \"Align has made significant long-term investments in innovation and in the Chinese market,\" said Joe Hogan, president and chief executive officer of Align Technology. \"We respect the role of China's courts in protecting intellectual property rights and are encouraged by this decision. Protecting intellectual property is essential to sustaining that innovation and ensuring continued investment in technologies that benefit doctors and patients. This decision reinforces the value and strength of Align's intellectual property portfolio and the significant investments we have made to develop industry-leading technologies. We remain committed to supporting fair competition, advancing innovation, and protecting our intellectual property rights while competing in the marketplace.\" Story Continues Align's Cutting-Edge Global Operations As a global leader in digital orthodontics and restorative dentistry with nearly 23.5 million Invisalign\u00ae patients treated worldwide, Align continues to transform the orthodontic industry through its global operations, advanced manufacturing capabilities, and doctor-directed treatment planning. Align's operations span the Americas, EMEA, and APAC regions, with clinical treatment planning centers in Costa Rica, Poland, China (Chengdu), Spain, France, Germany, and Japan. The company's global aligner manufacturing operations includes world-class facilities in Juarez, Mexico; Wroclaw, Poland; and Ziyang, China; Vienna, Austria; San Jose, CA; and a new aligner manufacturing facility coming online in 2027 in Hyderabad, India; together forming the backbone of the world's largest 3D printing netwo", "date_published": "2026-08-12T00:47:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "AFW"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AFW", "name": "Align Technology, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/9ffd5a89-eca6-4387-b5de-5a4a4ccc2d17/"}]}}, {"id": "source:1669df33eaba3e6eee9714c010f314c05d1e8287e8ce389932ee77aaead1dfe1", "url": "https://finance.yahoo.com/markets/stocks/articles/number-one-reason-keep-buying-130939372.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/number-one-reason-keep-buying-130939372.html", "title": "The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run", "content_text": "Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue competition. The dV5 supercycle is early, with only 1,700 of nearly 13,000 total systems upgraded and over 100 platform updates still planned. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks \u2014 and Intuitive Surgical didn't make the cut. Grab the names FREE today. ", "date_published": "2026-08-11T13:09:39+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Capital return", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:5e24f116e94ed703b1d3d5525dad9a6595c1e7a17622c24056a09e8b6634a74d", "url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-just-beat-210447165.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-just-beat-210447165.html", "title": "Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?", "content_text": "Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS of $2.80 exceeding expectations by $0.30. Despite that, the stock plunged due to mounting concerns about slowing domestic procedure growth. Worldwide procedures, da Vinci and Ion combined, grew around 16% compared to the prior year period, with Da Vinci procedures growing approximately 15% and Ion procedures growing approximately 36%. These trends disappointed investors accustomed to the company's historica", "date_published": "2026-08-10T21:04:47+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:41c92cab4ed8e228545e082a0cd11628d94fc82e3e905d6caa827d052eed5bbd", "url": "https://finance.yahoo.com/markets/stocks/articles/jim-cramer-sees-cheap-valuation-175313326.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/jim-cramer-sees-cheap-valuation-175313326.html", "title": "Jim Cramer Sees Cheap Valuation in Becton, Dickinson (BDX) After Q3 Beat and Raised Guidance", "content_text": "On August 6, Jim Cramer highlighted Becton, Dickinson and Company (NYSE:BDX) on CNBC's Mad Money following its third-quarter fiscal 2026 financial report and said: This morning, we got a very strong quarter from BD. That's the big medical technology and supply play... That was formerly known as Becton, Dickson. This was the first full quarter after they split off their biosciences and diagnostics business, something we loved. They posted a 9-cent earnings beat off a $3.14 basis, higher-than-expected revenue, up 5.4% year-over-year. They also said their full-year revenue growth would be toward ", "date_published": "2026-08-10T17:53:13+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Guidance", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:927f9ccad8a76401c0a14360109ddd557d24db34a3e730f18f16ee3d81dbc74b", "url": "https://finance.yahoo.com/healthcare/articles/isrg-trades-premium-p-e-144200115.html", "external_url": "https://finance.yahoo.com/healthcare/articles/isrg-trades-premium-p-e-144200115.html", "title": "ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?", "content_text": "Intuitive Surgical ISRG currently trades at a forward 12-month P/E ratio of 33.02X, above the Medical - Instruments industry's 26.53X, underscoring a valuation premium that investors must weigh against the company's growth prospects. The stock carries a Value Score of D, suggesting that shares are not particularly inexpensive despite the compression in its valuation multiple. Second-quarter 2026 results nevertheless provided a solid operating baseline. Revenues increased 19% year over year to $2.89 billion, while adjusted earnings per share (EPS) rose 28% to $2.80. Total procedures increased 1", "date_published": "2026-08-10T14:42:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:c2cae5d842d00a04b75cba6303708340781f4106ae510a70c537c7440b2dcae8", "url": "https://finance.yahoo.com/markets/stocks/articles/said-4-dividend-aristocrats-could-134539654.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/said-4-dividend-aristocrats-could-134539654.html", "title": "We Said These 4 Dividend Aristocrats Could Soar. Here\u2019s How They Did, Plus 3 New Picks.", "content_text": "Quick Read ABBV surged 47% and BDX gained 26% over the past year, both decisively beating the market as their overlooked dividend growth drove outsized returns. All four original picks kept raising dividends regardless of price, with PG marking its 70th consecutive year of increases and BF-A its 82nd. ALB, MDT, and SWK offer cyclical, defensive, and industrial dividend plays, each with dramatically improved free cash flow coverage heading into fiscal 2027. It sounds nuts, but SoFi1 is giving new Active Invest users up to $3,000 in stock for a limited time, and all it takes is a $50 deposit to ", "date_published": "2026-08-10T13:45:39+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:1f3a1d2d0e41f5a6089112952037dac0c453a7c78b4d75fbfa04ceabaf7c7c68", "url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-challenge-intuitive-124242559.html", "external_url": "https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-challenge-intuitive-124242559.html", "title": "Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava\u2019s FDA Approval?", "content_text": "Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J's MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon relationships, and a rapidly expanding da Vinci 5 platform. The question for investors is not whether OTTAVA can become a viable product, but whether Johnson & Johnson (NYSE:JNJ) can convert its differ", "date_published": "2026-08-10T12:42:42+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:d57b5b18af87a6c4c97d2c4c28d98cf6f03ef2e7928b939a0fe59ecb5ec288c0", "url": "https://seekingalpha.com/news/4629554-notable-healthcare-headlines-for-the-week-eli-lilly-novo-nordisk-and-pfizer-in-focus?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4629554-notable-healthcare-headlines-for-the-week-eli-lilly-novo-nordisk-and-pfizer-in-focus?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus", "content_text": "Wall Street\u2019s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, the benchmark S&P 500 gained 0.62%, and the tech-focused Nasdaq Composite jumped 1.3%. The S&P 500 Health Care Index Sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 1.92% during the week. The top S&P 500 healthcare gainers and losers for the last week are as follows: TOP GAINERS: Charles River Laboratories International (CRL [https://seekingalpha.com/symbol/CRL]) +15.04% Veeva Systems (VEE", "date_published": "2026-08-09T13:05:04+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:515bcd405913ec9cc97993d4bd05c5b4be8461c7f08b249e84f376290d0f491f", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Die Carl Zeiss Meditec AG hat die Analystenprognosen knapp \u00fcbertroffen, und die Analysten haben ihre Prognosen nach oben korrigiert", "content_text": "Die Carl Zeiss Meditec AG hat die Analystenprognosen knapp \u00fcbertroffen, und die Analysten haben ihre Prognosen nach oben korrigiert", "date_published": "2026-08-09T06:40:59+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Market update", "AFX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AFX", "name": "Carl Zeiss Meditec AG", "sentiment_url": "https://sharemaestro.com/sentiment/27aec015-4476-4ce0-8bd1-c906a61de745/"}]}}, {"id": "source:4d6044cd095ea1527e603f413771b7919d6def5adfe98c14cc6ec7e1e34189db", "url": "https://finance.yahoo.com/markets/stocks/articles/becton-dickinson-bdx-stock-sees-051039429.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/becton-dickinson-bdx-stock-sees-051039429.html", "title": "Becton Dickinson (BDX) Stock Sees Modest Fair Value Lift After Mixed Analyst Views", "content_text": "Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Becton Dickinson has seen its analyst fair value estimate move from US$181.23 to US$189.58, signaling a refreshed price target framework that investors are watching closely. This shift reflects how recent research is weighing the solid fiscal Q3 beat, product updates, and mixed views on 2027 utilization and margin risk. As you read on, you will see how these moving pieces shape the evolving narrative around Becton Dickinson and what that could mean for your own assessment of ", "date_published": "2026-08-09T05:10:39+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:ba0d67fee27205d645a1b06dcd2e7dd93826039a4894bb643f53aaa14cfc74cf", "url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-stock-looks-020803082.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-stock-looks-020803082.html", "title": "Intuitive Surgical (ISRG) Stock Looks Fairly Valued Despite Its 33% Slide", "content_text": "Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Intuitive Surgical stock has had a difficult start to 2026, with the share price down 32.6% year to date, while the Discounted Cash Flow (DCF) intrinsic value estimate now points to a level that is broadly in line with where the market is pricing the company. The year to date decline of 32.6% raises the question of whether recent weakness is now fully reflected in the share price. Management commentary around durable demand for platforms like da Vinci 5 ", "date_published": "2026-08-09T02:08:03+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:d4bf15b2230cbd7b388ab35f957cf11c1c7f0b4d4233cedd8aa0b69c8eb232a6", "url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-bylaw-changes-011205591.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-bylaw-changes-011205591.html", "title": "What Do Intuitive Surgical (ISRG) Bylaw Changes Mean For Shareholders?", "content_text": "Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Intuitive Surgical (NasdaqGS: ISRG) has approved amendments to its bylaws, updating shareholder voting rules, nomination processes, and procedural requirements in line with recent SEC universal proxy regulations. The revised bylaws clarify how proxy solicitations are conducted and what shareholders must disclose when putting forward director nominees or other proposals. The changes affect how investors can engage with the company on governance matters and may influence future proxy conte", "date_published": "2026-08-09T01:12:05+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:9efe49e3b1792aa645bcae32f6539998e80198bbf3a219d381c83eee4a180ea9", "url": "https://finance.yahoo.com/healthcare/articles/why-becton-dickinson-bdx-6-002052815.html", "external_url": "https://finance.yahoo.com/healthcare/articles/why-becton-dickinson-bdx-6-002052815.html", "title": "Why Becton Dickinson (BDX) Is Up 6.8% After Q3 Beat And GLP-1 Delivery Partnerships", "content_text": "Becton, Dickinson and Company recently reported third-quarter fiscal 2026 results, with sales rising to US$4,983 million while net income fell to US$377 million, and modestly raised its full-year outlook for low single-digit plus GAAP revenue growth. Alongside these earnings, BD highlighted strong momentum in biologic drug delivery and GLP-1\u2013related partnerships, including a new semaglutide pen collaboration with EMS in Brazil, underscoring the growing role of its Vystra Injection Pen platform in chronic disease treatment. We'll now look at how BD's stronger-than-expected FX-neutral revenue gr", "date_published": "2026-08-09T00:20:52+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:cfa2e9eeef0f04003ff3ff3d17190b682d47e0feabacf8398b58a2ff1baa3870", "url": "https://www.nasdaq.com/articles/medtronic-vs-intuitive-surgical-which-medtech-stock-better-buy-right-now", "external_url": "https://www.nasdaq.com/articles/medtronic-vs-intuitive-surgical-which-medtech-stock-better-buy-right-now", "title": "Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?", "content_text": "Key Points Medtronic has launched new devices that will help further improve its financial results. Intuitive Surgical's latest da Vinci system could expand its addressable market. Each stock will appeal to investors with different priorities. 10 stocks we like better than Medtronic \u203a Medtronic(NYSE: MDT) and Intuitive Surgical(NASDAQ: ISRG), two medical device leaders, haven't performed well this year. While weakness in the broader healthcare sector hasn't helped, they have both encountered company-specific issues that have contributed to their lagging the market. The good news is that there ", "date_published": "2026-08-08T21:20:00+00:00", "authors": [{"name": "nasdaq.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:0228fda7a01299989d2cdb3dc45402850ea86f8309b6e3713d2645b01b96fb53", "url": "https://www.nasdaq.com/articles/competition-heating-heres-why-intuitive-surgical-might-still-be-smartest-bet-medtech", "external_url": "https://www.nasdaq.com/articles/competition-heating-heres-why-intuitive-surgical-might-still-be-smartest-bet-medtech", "title": "Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech", "content_text": "Key Points Intuitive Surgical makes the da Vinci surgical robot, with 11,710 systems in use globally. Medical device competitors Medtronic and Johnson & Johnson are bringing out their own surgical robots. Intuitive Surgical's largest revenue source isn't the sale of new da Vinci systems.10 stocks we like better than Intuitive Surgical \u203a Intuitive Surgical(NASDAQ: ISRG) can be hard to own because the stock is prone to deep drawdowns. It is in a drawdown right now, with the stock down roughly 40% from its early 2025 high. Even after that drop, the price-to-earnings ratio remains lofty at 42x. Th", "date_published": "2026-08-08T16:35:00+00:00", "authors": [{"name": "nasdaq.com"}], "tags": ["Earnings", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:ef97591fe7287717984e55a5dbfd4afdc7056c911aa271ab0319d5876ea6e60b", "url": "https://finance.yahoo.com/healthcare/articles/robotic-surgery-leader-intuitive-surgical-110549493.html", "external_url": "https://finance.yahoo.com/healthcare/articles/robotic-surgery-leader-intuitive-surgical-110549493.html", "title": "The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%", "content_text": "Quick Read ISRG dropped 34% on a slower procedure growth guide, yet Q2 EPS of $2.80 crushed the $2.50 consensus for a fifth straight quarterly beat. ISRG trades 28% below Wall Street consensus while peers MDT and SYK fell less than 10% YTD, suggesting the market overcorrected on the category leader. Bernstein's $685 target implies 83% upside with the bull case hinging on the da Vinci 5 upgrade cycle mirroring the prior seven-year Xi ramp. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks \u2014 and Intuitive Surgical didn't make the cut. Grab the names FREE today. Intui", "date_published": "2026-08-08T11:05:49+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:3d15ccb5192b8cb796fda58a56225df471cb2fa82d8e01ec0928b3d7cbdbdece", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1FRWphdFN1RkRMSDhPZHdnVXMxdVZ1ODVVNkFYN213TXMwN01JZktGMTdod2hHRmdGSE9hWE5lcUpaYzJuSlVkSzRRejN1VnBMRXhvZWtYaXZkeGVwUnZkZ0ZGV2Q?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1FRWphdFN1RkRMSDhPZHdnVXMxdVZ1ODVVNkFYN213TXMwN01JZktGMTdod2hHRmdGSE9hWE5lcUpaYzJuSlVkSzRRejN1VnBMRXhvZWtYaXZkeGVwUnZkZ0ZGV2Q?oc=5", "title": "Intuitive Surgical Inc (ISRG) Aktuelle Aktien-News", "content_text": "Intuitive Surgical Inc (ISRG) Aktuelle Aktien-News", "date_published": "2026-08-08T10:07:58+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:3f06f522806ff27616195570e12dea997b75debc4e2f7f1715b10b2c12e98530", "url": "https://finance.yahoo.com/healthcare/articles/becton-dickinson-co-bdx-q3-030409755.html", "external_url": "https://finance.yahoo.com/healthcare/articles/becton-dickinson-co-bdx-q3-030409755.html", "title": "Becton Dickinson & Co (BDX) (Q3 2026) Earnings Call Highlights: Strong Revenue Growth and ...", "content_text": "This article first appeared on GuruFocus. Revenue: $5 billion, up 4.4% on an FX-neutral basis. Adjusted Operating Margin: 24.9%, down 130 basis points versus the prior year. Adjusted Gross Margin: 54.3%, down 100 basis points versus the prior year. Adjusted EPS: $3.23, up 4.9%. Free Cash Flow: $1.7 billion year to date, an increase of 45% versus the prior year. Segment Performance: Medical Essentials grew 3.2%, Connected Care grew 4.4%, BioPharma Systems grew 5.2%, and Interventional grew 5.5%. Guidance: Full-year revenue growth expected toward the high end of the low single-digit FX-neutral r", "date_published": "2026-08-08T03:04:09+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:8275aaca16e97b6cad3acb7f5290224a6caff9add2f9688d8187f3af58028b7c", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTFBFUVVNZ0lmeFpmSmVMd01Hb001Z0p0UHdVNERYRl9udHRtb01id1hSQXZ0M2lHb2lRaC1LTzRfZTZ5cGdtTXRGNFl2X1hYb1F3MkJMTjlDRWhBeDU5MUduODR6TUtFdmJ6Qnc?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiakFVX3lxTFBFUVVNZ0lmeFpmSmVMd01Hb001Z0p0UHdVNERYRl9udHRtb01id1hSQXZ0M2lHb2lRaC1LTzRfZTZ5cGdtTXRGNFl2X1hYb1F3MkJMTjlDRWhBeDU5MUduODR6TUtFdmJ6Qnc?oc=5", "title": "Intuitive Surgical Inc (ISRG) Aktienanalyse & Prognose", "content_text": "Intuitive Surgical Inc (ISRG) Aktienanalyse & Prognose", "date_published": "2026-08-07T22:08:32+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "IUI1"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IUI1", "name": "Intuitive Surgical, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/dde42408-63d5-4895-a259-d88509f63e45/"}]}}, {"id": "source:39e3c04bca413bdfd67e5c425720313deb9affd702c0135d25a8fdfc445fd3d9", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNOGRKWDlYc0pCX3p5aTA5WUg1bkdkclg4WTdsN2pRVGk3T1VwbktzRXVyMGF6aUw4TzlFVjVlaFpYR0xRMTdQVEtMOFdJaExrQThCMXlxXzF1U0NTb2tGZEpWS2EtTEstamtieUIyQVlIcEN6ZDJoTnUwZ2g5VGwwWHgzVlhHNUdaNlprZE0tNmJCMzNhR1pZZ2lqd19ENUJFbWoyb0JreUdmOFd5N2RldUdVaC0wVG02U09UbUVFdi0yZmk4ZHFkT2JHYWZKRDJDbklHbG1YZTk2Z3NPRlFlZWoxbw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNOGRKWDlYc0pCX3p5aTA5WUg1bkdkclg4WTdsN2pRVGk3T1VwbktzRXVyMGF6aUw4TzlFVjVlaFpYR0xRMTdQVEtMOFdJaExrQThCMXlxXzF1U0NTb2tGZEpWS2EtTEstamtieUIyQVlIcEN6ZDJoTnUwZ2g5VGwwWHgzVlhHNUdaNlprZE0tNmJCMzNhR1pZZ2lqd19ENUJFbWoyb0JreUdmOFd5N2RldUdVaC0wVG02U09UbUVFdi0yZmk4ZHFkT2JHYWZKRDJDbklHbG1YZTk2Z3NPRlFlZWoxbw?oc=5", "title": "Becton Dickinson Aktie steigt nach \u00fcberzeugenden Quartalszahlen und angehobener Prognose", "content_text": "Becton Dickinson Aktie steigt nach \u00fcberzeugenden Quartalszahlen und angehobener Prognose", "date_published": "2026-08-06T11:45:00+00:00", "authors": [{"name": "Investing.com Deutsch"}], "tags": ["Market update", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:94f4403ae730205a4a411805524546557445d6c4107bdd8a3133f50b78a506e2", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPMDItOEJnQWx0dURIeDZxZHg0RE95QnJyTUxoOTdTRGtNZXBKS3AyLVAya0NSaDVfYmVsLWIweHVIaUU2bm1CUEROOVpadzBCZTFNbExDNWoyRUZWQjdETHdsTmxHTk1sdDVYdmdHRlFtMWJWX3lRaGdRTlBLb0tvVjFweHZ6SF8wMms5Nk1WN1p0YmVJaE8xQ0pRemZGQ0hDZ2tQSUxjWTFYS1YxRWt3WXNvWDRmYktYX2hVVkFmU2hrdjJuYzI2MzBUWmtPVTVaTUpUdy0wZXRFeGtRbXpoNHluZHUzMGlLLXJzSThEVEhuMGp3T2FhTw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPMDItOEJnQWx0dURIeDZxZHg0RE95QnJyTUxoOTdTRGtNZXBKS3AyLVAya0NSaDVfYmVsLWIweHVIaUU2bm1CUEROOVpadzBCZTFNbExDNWoyRUZWQjdETHdsTmxHTk1sdDVYdmdHRlFtMWJWX3lRaGdRTlBLb0tvVjFweHZ6SF8wMms5Nk1WN1p0YmVJaE8xQ0pRemZGQ0hDZ2tQSUxjWTFYS1YxRWt3WXNvWDRmYktYX2hVVkFmU2hrdjJuYzI2MzBUWmtPVTVaTUpUdy0wZXRFeGtRbXpoNHluZHUzMGlLLXJzSThEVEhuMGp3T2FhTw?oc=5", "title": "Becton, Dickinson: Bereinigter Gewinn und Umsatz im dritten Gesch\u00e4ftsquartal steigen; Prognose f\u00fcr bereinigtes EPS 2026 angehoben", "content_text": "Becton, Dickinson: Bereinigter Gewinn und Umsatz im dritten Gesch\u00e4ftsquartal steigen; Prognose f\u00fcr bereinigtes EPS 2026 angehoben", "date_published": "2026-08-06T11:18:19+00:00", "authors": [{"name": "MarketScreener Schweiz"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:8742e62f09bd015c837f2191412eaf59267c8db6a02bbf51617fc38b94498e3a", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQQ1htQ2d4TWR0ZVVBTGhlWkJmNGwwNm5fa2RUNTZ5R1lXUTlmLUVpRjZsamhsRWEwcEpuQy16Mm1RUktTUzY0VW90YVVnakpMa3JnMVBpR04tRk1qV1NuajBHMHlKbmN2Z0toelg0VVNOa0dCeHA3VDJWWC1va0JLVTNXcVNQMjE4dmNIbUttSEVhX3lOZG82YU1xdU9kWUotSmJXbmJwRlRGREdMM090NjN3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQQ1htQ2d4TWR0ZVVBTGhlWkJmNGwwNm5fa2RUNTZ5R1lXUTlmLUVpRjZsamhsRWEwcEpuQy16Mm1RUktTUzY0VW90YVVnakpMa3JnMVBpR04tRk1qV1NuajBHMHlKbmN2Z0toelg0VVNOa0dCeHA3VDJWWC1va0JLVTNXcVNQMjE4dmNIbUttSEVhX3lOZG82YU1xdU9kWUotSmJXbmJwRlRGREdMM090NjN3?oc=5", "title": "Becton Dickinson \u00fcbertrifft Erwartungen und hebt Prognose an", "content_text": "Becton Dickinson \u00fcbertrifft Erwartungen und hebt Prognose an", "date_published": "2026-08-06T10:39:00+00:00", "authors": [{"name": "Investing.com Deutsch"}], "tags": ["Market update", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:4d9ca169bba4c5d1a9b33f1a6d23163c682202b9fbddcf73ea162dbe6f52fd90", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE02TU5ob1BLLS02cjFtYk53aVFDTGhEOUZ2T2JyYWpRWkpUcUU5MHlteU9zYXRCQzFkMC1TMVZkUElyZnB5MGh1d1RieHNCY0pINEZhNjJwU2xqVWc5VkFsVFpXVHBQM1px?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE02TU5ob1BLLS02cjFtYk53aVFDTGhEOUZ2T2JyYWpRWkpUcUU5MHlteU9zYXRCQzFkMC1TMVZkUElyZnB5MGh1d1RieHNCY0pINEZhNjJwU2xqVWc5VkFsVFpXVHBQM1px?oc=5", "title": "Becton Dickinson and Co (BDX) Gewinnprognose: Zuk\u00fcnftige EPS & Umsatzwachstumsprognosen", "content_text": "Becton Dickinson and Co (BDX) Gewinnprognose: Zuk\u00fcnftige EPS & Umsatzwachstumsprognosen", "date_published": "2026-08-06T07:00:00+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "BOX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOX", "name": "Becton, Dickinson and Company", "sentiment_url": "https://sharemaestro.com/sentiment/f5080ec9-f7c4-4462-8c86-3a0fe19a51c4/"}]}}, {"id": "source:454ea3e38a5c1e572cf428a22a97483c79111a21fdc0709b3721d4dfb85add84", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSzhVQ0xkWHVEMEZNaWc1X0FsbW5JdFZySUQ5Tm9qaWl0UGYtNU82Y0FWdE9MblR5aVFZX3pBaDktMnJRMlZZc3NjaGZxWXlXN3NWVVE5eU9zTFJBTDNqX3QwYWhBRkszTVhhMjJscEdtNFRKOHpRbkNWWDBXak5zX2liU0ZmUGw0NEt6dndfNVlYa3dNcXFHUlFENEtrT3hINWF6aXRJX25LYXdEUmVj?oc=5", "external_url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSzhVQ0xkWHVEMEZNaWc1X0FsbW5JdFZySUQ5Tm9qaWl0UGYtNU82Y0FWdE9MblR5aVFZX3pBaDktMnJRMlZZc3NjaGZxWXlXN3NWVVE5eU9zTFJBTDNqX3QwYWhBRkszTVhhMjJscEdtNFRKOHpRbkNWWDBXak5zX2liU0ZmUGw0NEt6dndfNVlYa3dNcXFHUlFENEtrT3hINWF6aXRJX25LYXdEUmVj?oc=5", "title": "Carl Zeiss Meditec Aktie: SMILE pro soll Effizienz steigern", "content_text": "Carl Zeiss Meditec Aktie: SMILE pro soll Effizienz steigern", "date_published": "2026-07-24T07:00:00+00:00", "authors": [{"name": "B\u00f6rse Express"}], "tags": ["Market update", "AFX"], "_sharemaestro": {"country": "Germany", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AFX", "name": "Carl Zeiss Meditec AG", "sentiment_url": "https://sharemaestro.com/sentiment/27aec015-4476-4ce0-8bd1-c906a61de745/"}]}}]}